Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection.
about
Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining ConditionsManagement of HCV-Associated Liver Cirrhosis.Combination ledipasvir-sofosbuvir for the treatment of chronic hepatitis C virus infection: a review and clinical perspectiveNext Steps Toward Eradication of Hepatitis C in the Era of Direct Acting AntiviralsKASL clinical practice guidelines: management of hepatitis CDirect anti-HCV agentsAdvances in hepatitis C therapy: What is the current state - what come's next?Role of liver transplantation in human immunodeficiency virus positive patientsImpact of new treatment options for hepatitis C virus infection in liver transplantationHIV/HCV Antiviral Drug Interactions in the Era of Direct-acting AntiviralsSystematic review and meta-analysis of hepatitis C virus infection and HIV viral load: new insights into epidemiologic synergyPotential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected PatientsGeno2pheno[HCV] - A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral AgentsTreatment optimization for HIV/HCV co-infected patients.HIV, Aging, and Viral Coinfections: Taking the Long View.Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016.Barriers to Hepatitis C Virus (HCV) Treatment Initiation in Patients With Human Immunodeficiency Virus/HCV Coinfection: Lessons From the Interferon Era.Highly Successful Hepatitis C Virus (HCV) Treatment Outcomes in Human Immunodeficiency Virus/HCV-Coinfected Patients at a Large, Urban, Ryan White Clinic.Minimum target prices for production of direct-acting antivirals and associated diagnostics to combat hepatitis C virus.Ledipasvir/Sofosbuvir: a review of its use in chronic hepatitis C.Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain.Human immunodeficiency virus and liver disease: An update.Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis.Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulationCumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.Recent advances in management of the HIV/HCV coinfected patient.Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration.Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.Time trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era: 1997-2012.Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIVSofosbuvir and ledipasvir for HIV/HCV co-infected patients.Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus CoinfectionSASLT guidelines: Update in treatment of Hepatitis C virus infection.An Unexpected Interaction between Sofosbuvir/Ledipasvir and Atorvastatin and Colchicine Causing Rhabdomyolysis in a Patient with Impaired Renal Function.Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment.Safety analysis of sofosbuvir and ledipasvir for treating hepatitis C.Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.What does the pharmacological future of treating chronic hepatitis C look like?
P2860
Q26740117-F5AEF620-C663-4578-88A4-5A33A1BD7767Q26740320-3C1577A0-A428-40D5-8B5E-46B3EE075AFEQ26746910-88A0BBC3-8D99-48AE-9EC7-BFC0FFA7D9CEQ26747561-11BC3F57-2C3B-49D0-9CF1-3454A82CF4C3Q26752471-F7269D03-CD88-4A64-BADE-6F584056D943Q26767329-F3AD39B9-936A-4D4B-9CAA-86A2447FCD92Q26770036-99E991D1-4C70-4A0D-A837-F8A38BAF53B3Q26775931-0470FD88-ACAC-4726-8F8C-81727F12A03DQ26782017-82601359-C083-4D78-888A-223C41FD36F5Q28073489-6A212962-CA87-493B-B7C5-85B35AFCE62FQ28077305-A19C3AD4-1150-47DD-9E32-8A65A6C4C852Q28550423-89DD21DF-70F0-4E9F-B1A1-D9357EF0B6D4Q28552269-E5E8F9E8-AB8D-415F-9038-9A29BC9A33CDQ30235034-D5A67A59-CF6A-422D-8084-CBF57D96964AQ30245486-D0F49F05-6486-4C15-B8B4-BD544F371191Q30355190-A2E0D3E9-2346-48A3-BAA8-97040ED19984Q33629538-93814343-D8F1-4137-A622-5CE4FB62586AQ33647154-216C76D3-CAAA-4EAA-BACA-295FE2E3EEB0Q34452419-F926C258-B4E3-4DFF-97DD-6EC6F7887484Q34470061-233827B7-26E9-4332-B829-671AF5A02CE3Q36167452-28724C54-58ED-42D5-AB29-47A158A0F9DCQ36378109-2696BF4C-9CC8-4FD7-8AF8-9BF016C4B40AQ36399193-E1DF292D-510B-4DC6-ADAD-B2F9380A7FE6Q36444618-DBD8427E-6514-4FDC-9C20-7F0F4333B8CEQ36459660-B446D985-6634-4000-AF21-2F3DCBF0E1DFQ36575497-E2CF1E0F-15DD-4418-8D73-782628B9A86BQ36837502-828D5C04-B7A8-4168-8420-7FC64B950D89Q36875036-2A58F8A2-8B3A-4FDE-B93F-10EEB9D432BDQ36967076-3A82D8EF-099F-403F-BEE2-1D20C79AC290Q37047999-05EE76E6-0E45-4EB3-8BB4-ABAD21AD22C8Q37055228-1209C4B2-F252-4223-BE78-99DD4683C028Q37055231-3D053E1B-BDD8-4502-89F2-5AB3C251BFF1Q37058681-ABD1ABF9-68B2-41FF-9CAD-9D9A1A4DB3A8Q37091595-9F7C29CC-C7CD-4843-90B9-078748EA218EQ37216507-9D6FAA6F-CDA7-44CD-AE63-3464D267E219Q37231750-CE9C88AC-484C-4F1A-B23A-1F04D252EE50Q37399645-8236A8CC-B32D-4E08-BB0F-8C4F64548FDFQ38516135-0DA3CAE3-C580-40A3-9EF7-8D34D4110E6DQ38554604-A9D92ED0-604F-4410-BA75-816B01D50C31Q38569681-AC940EFF-11BE-4073-94B6-6489205BFE2A
P2860
Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Virologic response following c ...... notype 1 and HIV co-infection.
@en
type
label
Virologic response following c ...... notype 1 and HIV co-infection.
@en
prefLabel
Virologic response following c ...... notype 1 and HIV co-infection.
@en
P2093
P50
P921
P356
P1476
Virologic response following c ...... notype 1 and HIV co-infection.
@en
P2093
Angie Price
Anita Kohli
Anu Osinusi
Brad J Wood
Cassie Seamon
Chloe Gross
Dimitra Bon
Eric G Meissner
Eva Herrmann
G Mani Subramanian
P304
P356
10.1001/JAMA.2015.1373
P407
P577
2015-03-01T00:00:00Z